| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
A B-cell–associated gene signature classification of diffuse large B-cell lymphoma by NanoString technology
|
Michaelsen, Thomas Yssing
|
|
|
|
13 |
p. 1542-1546
|
artikel
|
| 2 |
ADAMTS13 and VWF activities guide individualized caplacizumab treatment in patients with aTTP
|
Völker, Linus A.
|
|
|
|
13 |
p. 3093-3101
|
artikel
|
| 3 |
A global study for acute myeloid leukemia with RARG rearrangement
|
Zhu, Hong-Hu
|
|
|
|
13 |
p. 2972-2982
|
artikel
|
| 4 |
Allogeneic stem cell transplantation for high-risk acute leukemia and maintenance therapy: no time to waste
|
Scott, Bart L.
|
|
|
|
13 |
p. 3200-3204
|
artikel
|
| 5 |
Allogeneic transplantation using TLI-ATG conditioning for Hodgkin lymphoma after failure of autologous transplantation
|
Spinner, Michael A.
|
|
|
|
13 |
p. 1547-1550
|
artikel
|
| 6 |
American Society of Hematology, ABHH, ACHO, Grupo CAHT, Grupo CLAHT, SAH, SBHH, SHU, SOCHIHEM, SOMETH, Sociedad Panamena de Hematología, Sociedad Peruana de Hematología, and SVH 2023 guidelines for diagnosis of venous thromboembolism and for its management in special populations in Latin America
|
Neumann, Ignacio
|
|
|
|
13 |
p. 3005-3021
|
artikel
|
| 7 |
A multicenter analysis of the outcomes with venetoclax in patients with relapsed mantle cell lymphoma
|
Sawalha, Yazeed
|
|
|
|
13 |
p. 2983-2993
|
artikel
|
| 8 |
Analysis of carfilzomib cardiovascular safety profile across relapsed and/or refractory multiple myeloma clinical trials
|
Chari, Ajai
|
|
|
|
13 |
p. 1633-1644
|
artikel
|
| 9 |
A phase 2 trial of the histone deacetylase inhibitor panobinostat for graft-versus-host disease prevention
|
Perez, Lia
|
|
|
|
13 |
p. 2740-2750
|
artikel
|
| 10 |
A single-arm pilot study of a mobile health exercise intervention (GO-EXCAP) in older patients with myeloid neoplasms
|
Loh, Kah Poh
|
|
|
|
13 |
p. 3850-3860
|
artikel
|
| 11 |
A single F153Sβ3 mutation causes constitutive integrin αIIbβ3 activation in a variant form of Glanzmann thrombasthenia
|
Koukouritaki, Sevasti B.
|
|
|
|
13 |
p. 3180-3191
|
artikel
|
| 12 |
ATG vs thiotepa with busulfan and cyclophosphamide in matched-related bone marrow transplantation for thalassemia
|
Faulkner, Lawrence
|
|
|
|
13 |
p. 792-801
|
artikel
|
| 13 |
A thrombin-PAR1/2 feedback loop amplifies thromboinflammatory endothelial responses to the viral RNA analogue poly(I:C)
|
Subramaniam, Saravanan
|
|
|
|
13 |
p. 2760-2774
|
artikel
|
| 14 |
Autoimmune- and complement-mediated hematologic condition recrudescence following SARS-CoV-2 vaccination
|
Portuguese, Andrew Jay
|
|
|
|
13 |
p. 2794-2798
|
artikel
|
| 15 |
Bite-size introduction to canine hematologic malignancies
|
Atherton, Matthew J.
|
|
|
|
13 |
p. 4073-4084
|
artikel
|
| 16 |
Blood disease–causing and –suppressing transcriptional enhancers: general principles and GATA2 mechanisms
|
Bresnick, Emery H.
|
|
|
|
13 |
p. 2045-2056
|
artikel
|
| 17 |
Brentuximab vedotin after autologous transplantation in pediatric patients with relapsed/refractory Hodgkin lymphoma
|
Forlenza, Christopher J.
|
|
|
|
13 |
p. 3225-3231
|
artikel
|
| 18 |
Bridging therapy prior to axicabtagene ciloleucel for relapsed/refractory large B-cell lymphoma
|
Pinnix, Chelsea C.
|
|
|
|
13 |
p. 2871-2883
|
artikel
|
| 19 |
Burnout in US hematologists and oncologists: impact of compensation models and advanced practice provider support
|
Lee, Alfred Ian
|
|
|
|
13 |
p. 3058-3068
|
artikel
|
| 20 |
Calcium-RasGRP2-Rap1 signaling mediates CD38-induced migration of chronic lymphocytic leukemia cells
|
Mele, Silvia
|
|
|
|
13 |
p. 1551-1561
|
artikel
|
| 21 |
Challenges in applying diagnostic criteria for systemic mastocytosis
|
Boggs, Nathan A.
|
|
|
|
13 |
p. 3150-3154
|
artikel
|
| 22 |
Characterization of large in-frame von Willebrand factor deletions highlights differing pathogenic mechanisms
|
Cartwright, Ashley
|
|
|
|
13 |
p. 2979-2990
|
artikel
|
| 23 |
Cheng MP, Pandit A, Antin JH, et al. Safety and immunogenicity of conjugate quadrivalent meningococcal vaccination after hematopoietic cell transplantation. Blood Adv. 2018;2(11):1272-1276.
|
|
|
|
|
13 |
p. 1541
|
artikel
|
| 24 |
C1-inhibitor treatment in patients with severe complement-mediated autoimmune hemolytic anemia
|
de Boer, Esther C. W.
|
|
|
|
13 |
p. 3128-3139
|
artikel
|
| 25 |
Classification and genetics of pediatric B-other acute lymphoblastic leukemia by targeted RNA sequencing
|
Migita, Natacha Azussa
|
|
|
|
13 |
p. 2957-2971
|
artikel
|
| 26 |
Clinical and biological features of PTPN2-deleted adult and pediatric T-cell acute lymphoblastic leukemia
|
Alcantara, Marion
|
|
|
|
13 |
p. 1981-1988
|
artikel
|
| 27 |
Clinical efficacy of anakinra to mitigate CAR T-cell therapy–associated toxicity in large B-cell lymphoma
|
Strati, Paolo
|
|
|
|
13 |
p. 3123-3127
|
artikel
|
| 28 |
Cold agglutinin disease burden: a longitudinal analysis of anemia, medications, transfusions, and health care utilization
|
Mullins, Megan
|
|
|
|
13 |
p. 839-848
|
artikel
|
| 29 |
Comorbidities are risk factors for hospitalization and serious COVID-19 illness in children and adults with sickle cell disease
|
Mucalo, Lana
|
|
|
|
13 |
p. 2717-2724
|
artikel
|
| 30 |
Consensus recommendations on peripheral blood smear review: defining curricular standards and fellow competency
|
Chase, Matthew L.
|
|
|
|
13 |
p. 3244-3252
|
artikel
|
| 31 |
COO and MYC/BCL2 status do not predict outcome among patients with stage I/II DLBCL: a retrospective multicenter study
|
Barraclough, Allison
|
|
|
|
13 |
p. 2013-2021
|
artikel
|
| 32 |
COVID-19 and hairy-cell leukemia: an EPICOVIDEHA survey
|
Lamure, Sylvain
|
|
|
|
13 |
p. 3870-3874
|
artikel
|
| 33 |
CRISPR-based screens uncover determinants of immunotherapy response in multiple myeloma
|
Ramkumar, Poornima
|
|
|
|
13 |
p. 2899-2911
|
artikel
|
| 34 |
Dasatinib induces a dramatic response in a child with refractory juvenile xanthogranuloma with a novel MRC1-PDGFRB fusion
|
Eissa, Shaimaa S.
|
|
|
|
13 |
p. 2991-2995
|
artikel
|
| 35 |
Differential prognosis of single and multiple TP53 abnormalities in high-count MBL and untreated CLL
|
Griffin, Rosalie
|
|
|
|
13 |
p. 3169-3179
|
artikel
|
| 36 |
DLBCL patients treated with CD19 CAR T cells experience a high burden of organ toxicities but low nonrelapse mortality
|
Wudhikarn, Kitsada
|
|
|
|
13 |
p. 3024-3033
|
artikel
|
| 37 |
Dominant role of αIIbβ3 in platelet interactions with cross-linked fibrin fragment D-dimer
|
Buitrago, Lorena
|
|
|
|
13 |
p. 2939-2949
|
artikel
|
| 38 |
Editorial Board
|
|
|
|
|
13 |
p. i
|
artikel
|
| 39 |
Editorial Board
|
|
|
|
|
13 |
p. i
|
artikel
|
| 40 |
Editorial Board
|
|
|
|
|
13 |
p. i
|
artikel
|
| 41 |
Editorial Board
|
|
|
|
|
13 |
p. i
|
artikel
|
| 42 |
Editorial Board
|
|
|
|
|
13 |
p. i
|
artikel
|
| 43 |
Editorial Board
|
|
|
|
|
13 |
p. i
|
artikel
|
| 44 |
Editorial Board
|
|
|
|
|
13 |
p. i
|
artikel
|
| 45 |
Ensuring continuity of care of hematologic patients during COVID-19 pandemic in a tertiary hospital in Lombardy (Italy)
|
Fattizzo, Bruno
|
|
|
|
13 |
p. 2996-2999
|
artikel
|
| 46 |
ESRRB regulates glucocorticoid gene expression in mice and patients with acute lymphoblastic leukemia
|
Gallagher, Kayleigh M.
|
|
|
|
13 |
p. 3154-3168
|
artikel
|
| 47 |
Essential role for Gata2 in modulating lineage output from hematopoietic stem cells in zebrafish
|
Gioacchino, Emanuele
|
|
|
|
13 |
p. 2687-2700
|
artikel
|
| 48 |
Evolution of a chemosensitive core-binding factor AML into an aggressive leukemia with eosinophilic differentiation
|
Xiao, Wenbin
|
|
|
|
13 |
p. 1517-1521
|
artikel
|
| 49 |
Exposure-adjusted adverse events comparing blinatumomab with chemotherapy in advanced acute lymphoblastic leukemia
|
Stein, Anthony S.
|
|
|
|
13 |
p. 1522-1531
|
artikel
|
| 50 |
Fibrin protofibril packing and clot stability are enhanced by extended knob-hole interactions and catch-slip bonds
|
Asquith, Nathan L.
|
|
|
|
13 |
p. 4015-4027
|
artikel
|
| 51 |
Final results of the PUPs B-LONG study: evaluating safety and efficacy of rFIXFc in previously untreated patients with hemophilia B
|
Nolan, Beatrice
|
|
|
|
13 |
p. 2732-2739
|
artikel
|
| 52 |
First-in-human trial of rhIL-15 and haploidentical natural killer cell therapy for advanced acute myeloid leukemia
|
Cooley, Sarah
|
|
|
|
13 |
p. 1970-1980
|
artikel
|
| 53 |
First-line non–anthracycline-based chemotherapy for extranodal nasal-type NK/T-cell lymphoma: a retrospective analysis from the CLCG
|
Qi, Shu-Nan
|
|
|
|
13 |
p. 3141-3153
|
artikel
|
| 54 |
First report of emicizumab use in a female patient with severe hemophilia A
|
Verstraete, Géraldine
|
|
|
|
13 |
p. 2950-2952
|
artikel
|
| 55 |
Flow studies on human GPVI-deficient blood under coagulating and noncoagulating conditions
|
Nagy, Magdolna
|
|
|
|
13 |
p. 2953-2961
|
artikel
|
| 56 |
FOXP1 regulates oxidative stress, SIRT1 expression, and resistance to chemotherapies in acute myeloid leukemia cells
|
Levavasseur, Francoise
|
|
|
|
13 |
p. 3265-3275
|
artikel
|
| 57 |
Front Matter
|
|
|
|
|
13 |
p. ii
|
artikel
|
| 58 |
Gastrointestinal microbiota contributes to the development of murine transfusion-related acute lung injury
|
Kapur, Rick
|
|
|
|
13 |
p. 1651-1663
|
artikel
|
| 59 |
Gata1s mutant mice display persistent defects in the erythroid lineage
|
Ling, Te
|
|
|
|
13 |
p. 3253-3264
|
artikel
|
| 60 |
Genetic and evolutionary patterns of treatment resistance in relapsed B-cell lymphoma
|
Rushton, Christopher K.
|
|
|
|
13 |
p. 2886-2898
|
artikel
|
| 61 |
Genetic mutations and features of mantle cell lymphoma: a systematic review and meta-analysis
|
Hill, Holly A.
|
|
|
|
13 |
p. 2927-2938
|
artikel
|
| 62 |
Glasdegib as maintenance therapy for patients with AML and MDS patients at high risk for postallogeneic stem cell transplant relapse
|
Kent, Andrew
|
|
|
|
13 |
p. 3102-3108
|
artikel
|
| 63 |
Gowin K, Ballen K, Ahn KW, et al. Survival following allogeneic transplant in patients with myelofibrosis. Blood Adv. 2020;4(9):1965-1973.
|
|
|
|
|
13 |
p. 2751
|
artikel
|
| 64 |
HIF-1 directly induces TET3 expression to enhance 5-hmC density and induce erythroid gene expression in hypoxia
|
Cao, John Z.
|
|
|
|
13 |
p. 3053-3062
|
artikel
|
| 65 |
High-sensitivity next-generation sequencing MRD assessment in ALL identifies patients at very low risk of relapse
|
Short, Nicholas J.
|
|
|
|
13 |
p. 4006-4014
|
artikel
|
| 66 |
Human adult HSCs can be discriminated from lineage-committed HPCs by the expression of endomucin
|
Reckzeh, Kristian
|
|
|
|
13 |
p. 1628-1632
|
artikel
|
| 67 |
Huynh A, Arnold DM, Michael JV, et al. Characteristics of VITT antibodies in patients vaccinated with Ad26.COV2.S. Blood Adv. 2023;7(2):246-250.
|
|
|
|
|
13 |
p. 3113
|
artikel
|
| 68 |
Ilich A, Gernsheimer TB, Triulzi DJ, et al. Absence of hyperfibrinolysis may explain lack of efficacy of tranexamic acid in hypoproliferative thrombocytopenia. Blood Adv. 2023;7(6):900-908.
|
|
|
|
|
13 |
p. 3022
|
artikel
|
| 69 |
Impact of acquired del(17p) in multiple myeloma
|
Lakshman, Arjun
|
|
|
|
13 |
p. 1930-1938
|
artikel
|
| 70 |
Impact of allele-level HLA matching on outcomes after double cord blood transplantation in adults with malignancies
|
Fatobene, Giancarlo
|
|
|
|
13 |
p. 3297-3306
|
artikel
|
| 71 |
Impact of antithymocyte globulin on outcomes of allogeneic hematopoietic cell transplantation with TBI
|
Nagler, Arnon
|
|
|
|
13 |
p. 1950-1960
|
artikel
|
| 72 |
Impact of post-ASCT maintenance therapy on outcomes in patients with newly diagnosed multiple myeloma in Connect MM
|
Jagannath, Sundar
|
|
|
|
13 |
p. 1608-1615
|
artikel
|
| 73 |
Impaired exercise capacity in post–COVID-19 syndrome: the role of VWF-ADAMTS13 axis
|
Prasannan, Nithya
|
|
|
|
13 |
p. 4041-4048
|
artikel
|
| 74 |
Inflammation accelerates BCR-ABL1+ B-ALL development through upregulation of AID
|
Zhang, Ping
|
|
|
|
13 |
p. 4060-4072
|
artikel
|
| 75 |
Inflammation-driven activation of JAK/STAT signaling reversibly accelerates acute myeloid leukemia in vitro
|
Habbel, Jan
|
|
|
|
13 |
p. 3000-3010
|
artikel
|
| 76 |
Influenza-induced thrombocytopenia is dependent on the subtype and sialoglycan receptor and increases with virus pathogenicity
|
Jansen, A. J. Gerard
|
|
|
|
13 |
p. 2967-2978
|
artikel
|
| 77 |
Interaction of von Willebrand factor with blood cells in flow models: a systematic review
|
Arisz, Ryanne A.
|
|
|
|
13 |
p. 3979-3990
|
artikel
|
| 78 |
Interplay between hereditary and acquired factors determines the neutrophil counts in older individuals
|
Gagnon, Marie-France
|
|
|
|
13 |
p. 3232-3243
|
artikel
|
| 79 |
Invasive fungal infections after CLAG-M/CLAG chemotherapy for acute myeloid leukemia and high-grade myeloid neoplasms
|
Lindsay, Julian
|
|
|
|
13 |
p. 3140-3145
|
artikel
|
| 80 |
It’s high time to turn the spotlight on HbSC disease
|
Oluwole, Olubusola
|
|
|
|
13 |
p. 3320-3322
|
artikel
|
| 81 |
Landscape of immunoglobulin heavy chain gene repertoire and its clinical relevance to LPL/WM
|
Wang, Jun
|
|
|
|
13 |
p. 4049-4059
|
artikel
|
| 82 |
Large case-control study indicates no association of KIR genotype and risk of developing acute myeloid leukemia
|
Heidenreich, Falk
|
|
|
|
13 |
p. 2994-3004
|
artikel
|
| 83 |
Late molecular recurrences in patients with chronic myeloid leukemia experiencing treatment-free remission
|
Rousselot, Philippe
|
|
|
|
13 |
p. 3034-3040
|
artikel
|
| 84 |
Lenalidomide-associated B-cell ALL: clinical and pathologic correlates and sensitivity to lenalidomide withdrawal
|
Geyer, Mark B.
|
|
|
|
13 |
p. 3087-3098
|
artikel
|
| 85 |
Long-lived plasma cells in human bone marrow can be either CD19+ or CD19–
|
Brynjolfsson, Siggeir F.
|
|
|
|
13 |
p. 835-838
|
artikel
|
| 86 |
Long‐term safety and activity of NY-ESO‐1 SPEAR T cells after autologous stem cell transplant for myeloma
|
Stadtmauer, Edward A.
|
|
|
|
13 |
p. 2022-2034
|
artikel
|
| 87 |
Long-term survival with sickle cell disease: a nationwide cohort study of Medicare and Medicaid beneficiaries
|
Jiao, Boshen
|
|
|
|
13 |
p. 3276-3283
|
artikel
|
| 88 |
Low-dose cytarabine to prevent myeloid leukemia in children with Down syndrome: TMD Prevention 2007 study
|
Flasinski, Marius
|
|
|
|
13 |
p. 1532-1540
|
artikel
|
| 89 |
Low-dose radiation (4 Gy) with/without concurrent chemotherapy is highly effective for relapsed, refractory mantle cell lymphoma
|
Ning, Matthew S.
|
|
|
|
13 |
p. 2035-2039
|
artikel
|
| 90 |
Low toxicity and excellent outcomes in patients with DLBCL without residual lymphoma at the time of CD19 CAR T-cell therapy
|
Wudhikarn, Kitsada
|
|
|
|
13 |
p. 3192-3198
|
artikel
|
| 91 |
Low VWF: insights into pathogenesis, diagnosis, and clinical management
|
O'Donnell, James S.
|
|
|
|
13 |
p. 3191-3199
|
artikel
|
| 92 |
Maintenance therapy for high-risk acute leukemia after allogeneic hematopoietic cell transplantation: wait a minute
|
Soiffer, Robert J.
|
|
|
|
13 |
p. 3205-3208
|
artikel
|
| 93 |
Melanocortin/MC5R axis regulates the proliferation of hematopoietic stem cells in mice after ionizing radiation injury
|
Chen, Naicheng
|
|
|
|
13 |
p. 3199-3212
|
artikel
|
| 94 |
1.5 million platelet count limit at essential thrombocythemia diagnosis: correlations and relevance to vascular events
|
Gangat, Naseema
|
|
|
|
13 |
p. 3835-3839
|
artikel
|
| 95 |
Minimal residual disease negativity in multiple myeloma is associated with intestinal microbiota composition
|
Pianko, Matthew J.
|
|
|
|
13 |
p. 2040-2044
|
artikel
|
| 96 |
Molecular profiling identifies at least 3 distinct types of posttransplant lymphoproliferative disorder involving the CNS
|
Guney, Ekin
|
|
|
|
13 |
p. 3307-3311
|
artikel
|
| 97 |
Most adults with severe HbSC disease are not treated with hydroxyurea
|
Ghunney, William Kwesi
|
|
|
|
13 |
p. 3312-3319
|
artikel
|
| 98 |
Nationwide survey of systemic chronic active EBV infection in Japan in accordance with the new WHO classification
|
Yonese, Ichiro
|
|
|
|
13 |
p. 2918-2926
|
artikel
|
| 99 |
Natural history and rate of progression of retinopathy in adult patients with sickle cell disease: an 11-year follow-up study
|
Brandsen, Rajani P.
|
|
|
|
13 |
p. 3080-3086
|
artikel
|
| 100 |
Navigating the narrow bridge to CAR T-cell therapy
|
Yang, Joanna C.
|
|
|
|
13 |
p. 2884-2885
|
artikel
|
| 101 |
Nawas MT, Sanchez-Escamilla M, Devlin SM, et al. Dynamic EASIX scores closely predict nonrelapse mortality after allogeneic hematopoietic cell transplantation. Blood Adv. 2022;6(22):5898-5907.
|
|
|
|
|
13 |
p. 3323-3325
|
artikel
|
| 102 |
Novel approach to genetic analysis and results in 3000 hemophilia patients enrolled in the My Life, Our Future initiative
|
Johnsen, Jill M.
|
|
|
|
13 |
p. 824-834
|
artikel
|
| 103 |
Older patients with chronic myeloid leukemia face suboptimal molecular testing and tyrosine kinase inhibitor adherence
|
Shallis, Rory M.
|
|
|
|
13 |
p. 3213-3224
|
artikel
|
| 104 |
Olutasidenib (FT-2102) induces durable complete remissions in patients with relapsed or refractory IDH1-mutated AML
|
de Botton, Stéphane
|
|
|
|
13 |
p. 3117-3127
|
artikel
|
| 105 |
Outcomes after autologous hematopoietic cell transplantation in POEMS syndrome and comparison with multiple myeloma
|
Kansagra, Ankit
|
|
|
|
13 |
p. 3991-3995
|
artikel
|
| 106 |
Outcomes and molecular profile of oligomonocytic CMML support its consideration as the first stage in the CMML continuum
|
Calvo, Xavier
|
|
|
|
13 |
p. 3921-3931
|
artikel
|
| 107 |
Outcomes for patients with severe chronic neutropenia treated with granulocyte colony-stimulating factor
|
Dale, David C.
|
|
|
|
13 |
p. 3861-3869
|
artikel
|
| 108 |
Overlapping and unique substrate specificities of ST3GAL1 and 2 during hematopoietic and megakaryocytic differentiation
|
Zhang, Nanyan
|
|
|
|
13 |
p. 3945-3955
|
artikel
|
| 109 |
Parasite histones are toxic to brain endothelium and link blood barrier breakdown and thrombosis in cerebral malaria
|
Moxon, Christopher A.
|
|
|
|
13 |
p. 2851-2864
|
artikel
|
| 110 |
Partial trisomy 21 contributes to T-cell malignancies induced by JAK3-activating mutations in murine models
|
Rivera-Munoz, Paola
|
|
|
|
13 |
p. 1616-1627
|
artikel
|
| 111 |
Patterns of salivary microbiota injury and oral mucositis in recipients of allogeneic hematopoietic stem cell transplantation
|
Shouval, Roni
|
|
|
|
13 |
p. 2912-2917
|
artikel
|
| 112 |
Personalized risk model for predicting risk of acute coronary syndrome in patients with myelodysplastic syndromes
|
Montarello, Natalie
|
|
|
|
13 |
p. 3032-3035
|
artikel
|
| 113 |
Phase 1b study of the MDM2 inhibitor AMG 232 with or without trametinib in relapsed/refractory acute myeloid leukemia
|
Erba, Harry P.
|
|
|
|
13 |
p. 1939-1949
|
artikel
|
| 114 |
Phase 1 investigation of lenalidomide/rituximab plus outcomes of lenalidomide maintenance in relapsed CNS lymphoma
|
Rubenstein, James L.
|
|
|
|
13 |
p. 1595-1607
|
artikel
|
| 115 |
Phase 3 randomized trial of chemotherapy with or without oblimersen in older AML patients: CALGB 10201 (Alliance)
|
Walker, Alison R.
|
|
|
|
13 |
p. 2775-2787
|
artikel
|
| 116 |
Phenotypic and genetic characterizations of the Milan cohort of von Willebrand disease type 2
|
Seidizadeh, Omid
|
|
|
|
13 |
p. 4031-4040
|
artikel
|
| 117 |
Platelet activation and partial desensitization are associated with viral xenophagy in patients with severe COVID-19
|
Garcia, Cédric
|
|
|
|
13 |
p. 3884-3898
|
artikel
|
| 118 |
Platelet autoantibodies in the bone marrow of patients with immune thrombocytopenia
|
Shrestha, Sabrina
|
|
|
|
13 |
p. 2962-2966
|
artikel
|
| 119 |
Platelet-derived extracellular vesicles infiltrate and modify the bone marrow during inflammation
|
French, Shauna L.
|
|
|
|
13 |
p. 3011-3023
|
artikel
|
| 120 |
Polatuzumab vedotin as a salvage and bridging treatment in relapsed or refractory large B-cell lymphomas
|
Liebers, Nora
|
|
|
|
13 |
p. 2707-2716
|
artikel
|
| 121 |
Post hoc longitudinal assessment of the efficacy and safety of recombinant factor IX Fc fusion protein in hemophilia B
|
Shapiro, Amy D.
|
|
|
|
13 |
p. 3049-3057
|
artikel
|
| 122 |
Primary progression during frontline CIT associates with decreased efficacy of subsequent CD19 CAR T-cell therapy in LBCL
|
Perez, Ariel
|
|
|
|
13 |
p. 3970-3973
|
artikel
|
| 123 |
Prognostic impact of posttransplant FDG PET/CT scan in multiple myeloma
|
Kaddoura, Marcella
|
|
|
|
13 |
p. 2753-2759
|
artikel
|
| 124 |
Qi S, Milgrom S, Dabaja B, et al. Two distinct prognostic groups in advanced-stage Hodgkin lymphoma revealed by the presence and site of bulky disease. Blood Adv. 2020;4(9):2064-2072.
|
|
|
|
|
13 |
p. 2793
|
artikel
|
| 125 |
Randomized, double-blinded, placebo-controlled trial of allogeneic cord blood T-regulatory cells for treatment of COVID-19 ARDS
|
Gladstone, Douglas E
|
|
|
|
13 |
p. 3075-3079
|
artikel
|
| 126 |
Real-world data confirm the effectiveness of caplacizumab in acquired thrombotic thrombocytopenic purpura
|
Völker, Linus A.
|
|
|
|
13 |
p. 3085-3092
|
artikel
|
| 127 |
Real-world effectiveness of CPX-351 vs venetoclax and azacitidine in acute myeloid leukemia
|
Matthews, Andrew H.
|
|
|
|
13 |
p. 3997-4005
|
artikel
|
| 128 |
Reduced intensity conditioning for acute myeloid leukemia using melphalan- vs busulfan-based regimens: a CIBMTR report
|
Zhou, Zheng
|
|
|
|
13 |
p. 3180-3190
|
artikel
|
| 129 |
Reduced-intensity single-unit unrelated cord blood transplant with optional immune boost for nonmalignant disorders
|
Vander Lugt, Mark T.
|
|
|
|
13 |
p. 3041-3052
|
artikel
|
| 130 |
Reducing minimal residual disease with blinatumomab prior to HCT for pediatric patients with acute lymphoblastic leukemia
|
Keating, Amy K.
|
|
|
|
13 |
p. 1926-1929
|
artikel
|
| 131 |
Relationship of iothalamate clearance and NRM in patients receiving fludarabine and melphalan reduced-intensity conditioning
|
Kutzke, Jade L.
|
|
|
|
13 |
p. 3844-3849
|
artikel
|
| 132 |
Relative dose intensity of obinutuzumab-chlorambucil in chronic lymphocytic leukemia: a multicenter Italian study
|
Fresa, Alberto
|
|
|
|
13 |
p. 3875-3878
|
artikel
|
| 133 |
Replenishing exosomes from older bone marrow stromal cells with miR-340 inhibits myeloma-related angiogenesis
|
Umezu, Tomohiro
|
|
|
|
13 |
p. 812-823
|
artikel
|
| 134 |
Risk factors and appropriate therapeutic strategies for thrombotic microangiopathy after allogeneic HSCT
|
Matsui, Hiroyuki
|
|
|
|
13 |
p. 3169-3179
|
artikel
|
| 135 |
Risk for malignancies of infectious etiology among adult survivors of specific non-Hodgkin lymphoma subtypes
|
Herr, Megan M.
|
|
|
|
13 |
p. 1961-1969
|
artikel
|
| 136 |
Risk of infections associated with the use of bispecific antibodies in multiple myeloma: a pooled analysis
|
Mazahreh, Farah
|
|
|
|
13 |
p. 3069-3074
|
artikel
|
| 137 |
Ritz C, Meng W, Stanley NL, et al. Postvaccination graft dysfunction/aplastic anemia relapse with massive clonal expansion of autologous CD8+ lymphocytes. Blood Adv. 2020;4(7):1378-1382.
|
|
|
|
|
13 |
p. 2865
|
artikel
|
| 138 |
RPS15 mutations rewire RNA translation in chronic lymphocytic leukemia
|
Ntoufa, Stavroula
|
|
|
|
13 |
p. 2788-2792
|
artikel
|
| 139 |
Safety and efficacy of the combination of sonidegib and ruxolitinib in myelofibrosis: a phase 1b/2 dose-finding study
|
Gupta, Vikas
|
|
|
|
13 |
p. 3063-3071
|
artikel
|
| 140 |
SAKK 35/15: a phase 1 trial of obinutuzumab in combination with venetoclax in patients with previously untreated follicular lymphoma
|
Stathis, Anastasios
|
|
|
|
13 |
p. 3911-3920
|
artikel
|
| 141 |
SARS-CoV-2 infection associated with aplastic anemia and pure red cell aplasia
|
Lee, Nicholas C.J.
|
|
|
|
13 |
p. 3840-3843
|
artikel
|
| 142 |
Search for AL amyloidosis risk factors using Mendelian randomization
|
Saunders, Charlie N.
|
|
|
|
13 |
p. 2725-2731
|
artikel
|
| 143 |
SECTM1-based CAR T cells enriched with CD7-low/negative subsets exhibit efficacy in CD7-positive malignancies
|
Wei, Wenwen
|
|
|
|
13 |
p. 2941-2951
|
artikel
|
| 144 |
Selective modulation of activated protein C activities by a nonactive site–targeting nanobody library
|
Sim, Derek S.
|
|
|
|
13 |
p. 3036-3048
|
artikel
|
| 145 |
Shouval R, Fein JA, Cho C, et al. The Simplified Comorbidity Index: a new tool for prediction of nonrelapse mortality in allo-HCT. Blood Adv. 2022;6(5):1525-1535.
|
|
|
|
|
13 |
p. 3996
|
artikel
|
| 146 |
Single-cell ATAC-seq reveals GATA2-dependent priming defect in myeloid and a maturation bottleneck in lymphoid lineages
|
Avagyan, Serine
|
|
|
|
13 |
p. 2673-2686
|
artikel
|
| 147 |
Specific patterns of H3K79 methylation influence genetic interaction of oncogenes in AML
|
Kingsley, Molly C.
|
|
|
|
13 |
p. 3109-3122
|
artikel
|
| 148 |
Specific subtype distribution with impact on prognosis of TP53 single-hit and double-hit events in AML and MDS
|
Stengel, Anna
|
|
|
|
13 |
p. 2952-2956
|
artikel
|
| 149 |
Sphingomyelin encrypts tissue factor: ATP-induced activation of A-SMase leads to tissue factor decryption and microvesicle shedding
|
Wang, Jue
|
|
|
|
13 |
p. 849-862
|
artikel
|
| 150 |
STAT3β is a tumor suppressor in acute myeloid leukemia
|
Aigner, Petra
|
|
|
|
13 |
p. 1989-2002
|
artikel
|
| 151 |
Storage of red blood cells in alkaline PAGGGM improves metabolism but has no effect on recovery after transfusion
|
de Bruin, Sanne
|
|
|
|
13 |
p. 3899-3910
|
artikel
|
| 152 |
Structural, functional, and immunogenicity implications of F9 gene recoding
|
Katneni, Upendra K.
|
|
|
|
13 |
p. 3932-3944
|
artikel
|
| 153 |
Structure basis of the FERM domain of kindlin-3 in supporting integrin αIIbβ3 activation in platelets
|
Sun, Jiaojiao
|
|
|
|
13 |
p. 3128-3135
|
artikel
|
| 154 |
TAK-981, a SUMOylation inhibitor, suppresses AML growth immune-independently
|
Kim, Han Sun
|
|
|
|
13 |
p. 3155-3168
|
artikel
|
| 155 |
Targeted FGFR inhibition results in a durable remission in an FGFR1-driven myeloid neoplasm with eosinophilia
|
Kasbekar, Monica
|
|
|
|
13 |
p. 3136-3140
|
artikel
|
| 156 |
Telomere shortening correlates with leukemic stem cell burden at diagnosis of chronic myeloid leukemia
|
Bouillon, Anne-Sophie
|
|
|
|
13 |
p. 1572-1579
|
artikel
|
| 157 |
Ten-year outcome of patients with acute myeloid leukemia not treated with allogeneic transplantation in first complete remission
|
Vasu, Sumithira
|
|
|
|
13 |
p. 1645-1650
|
artikel
|
| 158 |
The antagonistic duality of NPM1 mutations in AML
|
Khan, Irum
|
|
|
|
13 |
p. 4028-4030
|
artikel
|
| 159 |
The common VWF single nucleotide variants c.2365A>G and c.2385T>C modify VWF biosynthesis and clearance
|
Mufti, Ahmad H.
|
|
|
|
13 |
p. 1585-1594
|
artikel
|
| 160 |
The contribution of rare copy number variants in FAS toward pathogenesis of autoimmune lymphoproliferative syndrome
|
Jevtich, Kathleen
|
|
|
|
13 |
p. 3974-3978
|
artikel
|
| 161 |
The dual PI3Kδ/CK1ε inhibitor umbralisib exhibits unique immunomodulatory effects on CLL T cells
|
Maharaj, Kamira
|
|
|
|
13 |
p. 3072-3084
|
artikel
|
| 162 |
The gut microbiota in patients with polycythemia vera is distinct from that of healthy controls and varies by treatment
|
Eickhardt-Dalbøge, Christina Schjellerup
|
|
|
|
13 |
p. 3326-3337
|
artikel
|
| 163 |
The incidence and natural history of dasatinib complications in the treatment of chronic myeloid leukemia
|
Fox, Lucy C.
|
|
|
|
13 |
p. 802-811
|
artikel
|
| 164 |
The spectrum and severity of bleeding in adolescents with low von Willebrand factor–associated heavy menstrual bleeding
|
Srivaths, Lakshmi
|
|
|
|
13 |
p. 3209-3216
|
artikel
|
| 165 |
The use of FDA-approved medications for preventing vaso-occlusive events in sickle cell disease
|
Cronin, Robert M.
|
|
|
|
13 |
p. 3114-3116
|
artikel
|
| 166 |
Transient and chronic childhood immune thrombocytopenia are distinctly affected by Fc-γ receptor polymorphisms
|
Schmidt, David E.
|
|
|
|
13 |
p. 2003-2012
|
artikel
|
| 167 |
Treatment-free remission after ceasing venetoclax-based therapy in patients with acute myeloid leukemia
|
Chua, Chong Chyn
|
|
|
|
13 |
p. 3879-3883
|
artikel
|
| 168 |
Trispecific killer engager CD16xIL15xCD33 potently induces NK cell activation and cytotoxicity against neoplastic mast cells
|
Don Yun, Hyun
|
|
|
|
13 |
p. 1580-1584
|
artikel
|
| 169 |
Undetectable measurable residual disease is associated with improved outcomes in AML irrespective of treatment intensity
|
Bazinet, Alexandre
|
|
|
|
13 |
p. 3284-3296
|
artikel
|
| 170 |
Up-front rituximab maintenance improves outcome in patients with follicular lymphoma: a collaborative Nordic study
|
Madsen, C.
|
|
|
|
13 |
p. 1562-1571
|
artikel
|
| 171 |
USP1 promotes the aerobic glycolysis and progression of T-cell acute lymphoblastic leukemia via PLK1/LDHA axis
|
Liu, Shuguang
|
|
|
|
13 |
p. 3099-3112
|
artikel
|
| 172 |
Value of embedded palliative care: outpatient palliative care and health care utilization for patients with hematologic malignancies
|
Tsang, Mazie
|
|
|
|
13 |
p. 3146-3149
|
artikel
|
| 173 |
Venetoclax and hypomethylating agents (HMAs) induce high response rates in MDS, including patients after HMA therapy failure
|
Ball, Brian J.
|
|
|
|
13 |
p. 2866-2870
|
artikel
|
| 174 |
Whole genome sequences discriminate hereditary hemorrhagic telangiectasia phenotypes by non-HHT deleterious DNA variation
|
Joyce, Katie E.
|
|
|
|
13 |
p. 3956-3969
|
artikel
|
| 175 |
Wild-type HIV infection after treatment with lentiviral gene therapy for β-thalassemia
|
Hongeng, Suradej
|
|
|
|
13 |
p. 2701-2706
|
artikel
|
| 176 |
Zhou Z, Nath R, Cerny J, et al. Reduced intensity conditioning for acute myeloid leukemia using melphalan- vs busulfan-based regimens: a CIBMTR report. Blood Adv. 2020;4(13):3180-3190.
|
|
|
|
|
13 |
p. 2752
|
artikel
|
| 177 |
Zinc for infection prevention in children with sickle cell anemia: a randomized double-blind placebo-controlled trial
|
Namazzi, Ruth
|
|
|
|
13 |
p. 3023-3031
|
artikel
|
Tijdschrift beschrijving